AI assistant
Sending…
LifeMD, Inc. — Director's Dealing 2017
Oct 27, 2017
33298_dirs_2017-10-27_e0a03c20-168c-4cff-9469-f7fe60ff9b74.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Immudyne, Inc. (IMMD)
CIK: 0000948320
Period of Report: 2017-10-16
Reporting Person: Schreiber Justin (Director, President, Immudyne PR, 10% Owner)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock, par value $0.01 | 1805272 | Indirect |
| Common Stock, par value $0.01 | 1375000 | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Warrant | $0.40 | 2018-11-01 | Common Stock, par value $0.01 (217391) | Indirect | |
| Warrant | $0.40 | 2019-01-01 | Common Stock, par value $0.01 (591745) | Indirect |
Footnotes
F1: Immudyne, Inc. retains a right to rescind 1,000,000 shares of Common Stock issued to JLS Ventures LLC in the event Immudyne Puerto Rico does not distribute at least $500,000 to Immudyne, Inc. by December 31, 2017.
More from LifeMD, Inc.
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 6
Annual Report
2026
Apr 30
Regulatory Filings
2026
Apr 1
Regulatory Filings
2026
Mar 23
Regulatory Filings
2026
Jan 6
Director's Dealing
2025
Dec 11
Regulatory Filings
2025
Nov 24
Interim / Quarterly Report
2025
Nov 17
Regulatory Filings
2025
Nov 17